Aortic stiffness in young patients with heterozygous familial hypercholesterolemia

被引:118
|
作者
Pitsavos, C [1 ]
Toutouzas, K [1 ]
Dernellis, J [1 ]
Skoumas, J [1 ]
Skoumbourdis, E [1 ]
Stefanadis, C [1 ]
Toutouzas, P [1 ]
机构
[1] Univ Athens, Hippakration Hosp, Dept Cardiol, GR-10679 Athens, Greece
关键词
D O I
10.1016/S0002-8703(98)70274-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Dyslipidemia is a primary risk factor for the development of atherosclerosis. Aortic distensibility is an important determinant of left ventricular function and coronary blood flow whose possible alterations in patients with dyslipidemia have not been fully investigated. Methods To assess the effect of dyslipidemia on the elastic properties of the aorta, we studied 60 patients (mean age 37 +/- 11 years) with heterozygous familial hypercholesterolemia and no manifest arterial disease and compared them with 20 of their normolipidemic siblings (mean age 34 +/- 10 years). Two indexes of the aortic elastic properties were measured: aortic distensibility was calculated by use of the formula: 2 x (AoS-AoD)/PP x AoD, and aortic stiffness index was calculated by use of the formula: In (SBP/DBP)/(AoS-AoD)/AoD, where AoS and AoD ore aortic root end-systolic and end-diastolic diameters, respectively, SEP and DBP are systolic and diastolic arterial pressure, respectively, and PP is pulse pressure. Internal aortic root diameters were measured at 3 cm above the aortic valve by use of two-dimensional guided M-mode transthoracic echocardiography, and arterial pressure was measured simultaneously at the brachial artery by sphygmomanometry. Results The mean aortic systolic and diastolic diameter index did not differ signifficantly between the two groups. In contrast, aortic distensibility was found to be significantly reduced in subjects with isolated familial hypercholesterolemia compared with that in the control group (2.15 +/- 1.72 cm(2).dynes.10(-6)vs 3.18 +/- 1.58 cm(2).dynes(-1).10(-6), p < 0.02), In addition, the mean aortic stiffness index was double in patients with familial hypercholesterolemia compared with that in normolipidemic subjects. Conclusions severe dyslipidemia does not overtly influence aortic dimensions but leads to impairment of aortic elastic properties before the occurrence of clinical manifestations of atherosclerotic disease.
引用
收藏
页码:604 / 608
页数:5
相关论文
共 50 条
  • [21] ALPHALIPOPROTEINS IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    MOORJANI, S
    GAGNE, C
    BRUN, LD
    TOUSSAINT, M
    LUPIEN, PJ
    UNION MEDICALE DU CANADA, 1980, 109 (04): : 530 - &
  • [22] GENETIC IDENTIFICATION OF HOMOZOGOUS FAMILIAL HYPERCHOLESTEROLEMIA AMONG PATIENTS WITH CLINICALLY DIAGNOSED HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Chaudhry, Ahsen
    Vesely, Kristin
    Trinder, Mark
    Brunham, Liam
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1473 - 1473
  • [23] Patients' attitudes toward detection of heterozygous familial hypercholesterolemia
    Andersen, LK
    Jensen, HK
    Juul, S
    Faergeman, O
    ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (05) : 553 - 560
  • [24] Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia
    Reeskamp, Laurens F.
    Kastelein, John J. P.
    Moriarty, Patrick M.
    Duell, P. Barton
    Catapano, Alberico L.
    Santos, Raul D.
    Ballantyne, Christie M.
    ATHEROSCLEROSIS, 2019, 280 : 109 - 117
  • [25] EVALUATION OF ARTERIAL STIFFNESS IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    Rodrigues, A. D. S.
    Oliveira, C. R. D.
    Pinheiro, R. P.
    Meneses, M. J. M.
    Alves, R. J.
    ATHEROSCLEROSIS, 2022, 355 : E221 - E221
  • [26] Assessment of arterial stiffness in patients with familial hypercholesterolemia
    Tada, Hayato
    Kawashiri, Masa-aki
    Nohara, Atsushi
    Inazu, Akihiro
    Mabuchi, Hiroshi
    Yamagishi, Masakazu
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (02) : 397 - 402
  • [27] Cascade Screening and Treatment Initiation in Young Adults with Heterozygous Familial Hypercholesterolemia
    Peterson, Amy L.
    Bang, Matthew
    Block, Robert C.
    Wong, Nathan D.
    Karalis, Dean G.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (14)
  • [28] Alirocumab efficacy in patients with double heterozygous, compound heterozygous, or homozygous familial hypercholesterolemia
    Hartgers, Merel L.
    Defesche, Joep C.
    Langslet, Gisle
    Hopkins, Paul N.
    Kastelein, John J. P.
    Baccara-Dinet, Marie T.
    Seiz, Werner
    Hamon, Sara
    Banerjee, Poulabi
    Stefanutti, Claudia
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (02) : 390 - 396
  • [29] Aortic Valve Calcification and Coronary Plaque Morphology in Japanese Heterozygous Familial Hypercholesterolemia Patients With Gene Mutation
    Yamamoto, Aya
    Sakai, Akiko
    Sekiguchi, Haruki
    Sato, Kayoko
    Fukushima, Kenji
    Sakai, Syuji
    Hagiwara, Nobuhisa
    CIRCULATION, 2017, 136
  • [30] AORTIC STENOSIS IN SUBJECTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN PROLONGED TREATMENT WITH STATINS.
    Marco-Benedi, V.
    Casado-Dominguez, J. M.
    Villa Pobo, R.
    Mateo-Gallego, R.
    Perez Calahorra, S.
    Sanchez-Hernandez, R.
    Blanco Nuez, M.
    Ortega-Martinez de Victoria, E.
    Amor Fernandez, A. J.
    Zambon, D.
    Sitges Carreno, M.
    Pedro-Botet, J.
    Puzo, J.
    Villarroel, T.
    Civeira, F.
    ATHEROSCLEROSIS, 2019, 287 : E182 - E182